Related Experiment Videos
Pelvic Ewing's sarcoma. Advances in treatment
Summary
Multidisciplinary treatment for pelvic Ewing's sarcoma, including chemotherapy and surgery, significantly improves survival rates. This approach offers better local control and survival compared to radiation and chemotherapy alone.
Area of Science:
- Oncology
- Surgical Oncology
- Pediatric Oncology
Background:
- Pelvic Ewing's sarcoma presents unique treatment challenges.
- Systemic spread and local control are key concerns in managing this rare bone tumor.
Purpose of the Study:
- To evaluate the efficacy of a multidisciplinary treatment approach for pelvic Ewing's sarcoma.
- To compare outcomes of different treatment modalities for local pelvic lesion control and overall survival.
Main Methods:
- Retrospective analysis of eighteen patients with pelvic Ewing's sarcoma.
- Multidisciplinary treatment involving initial chemotherapy, surgical resection, and radiation therapy.
Main Results:
- Chemotherapy effectively controlled systemic spread.
- Surgical resection combined with chemotherapy yielded statistically superior local control compared to radiation and chemotherapy alone.
- A twofold increase in survival rate was observed in patients who underwent resection at 36-month follow-up.
Conclusions:
- A treatment strategy of initial chemotherapy, wide marginal resection, perimeter radiation, and adjuvant chemotherapy is recommended for pelvic Ewing's sarcoma.
- This optimized approach may improve survival rates, bringing them closer to those seen in more favorable anatomical locations.